ReviewCurrent microbiology2026
Membrane Biofouling: Current Understanding and Future Perspectives- An Overview.
Review in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Membrane technology is a compelling alternative for addressing some water quality issues on a global scale. Despite the demonstrated success of membrane technology, biofouling remains a persistent problem in membrane filtration processes. The impact of biofouling compromises the application and efficiency of the filtration processes by shortening membrane lifespan, reducing permeate output, increasing the energy requirements, and increasing the transmembrane pressure. All these factors combined impact treatment plant operations. Biofouling is reported to contribute ~ 45% of all membrane fouling and between 20 and 30% of operating costs. This review critically examines the factors driving membrane biofouling and evaluates conventional mitigation strategies, highlighting their limited long-term effectiveness, high operational costs, and environmental drawbacks. Various technologies discussed in this paper have been developed to mitigate biofouling; however, due to the complexity and intractability of biofouling, their efficiency is limited. Hybrid systems are in part proposed as a sustainable antibiofouling approach to overcome the limitations of conventional biofouling mitigation technologies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.